Phenotypic and functional characterisation of the luminal cell hierarchy of the mammary gland
Open accessThe DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Abstract
Introduction: The organisation of the mammary epithelial hierarchy is poorly understood. Our hypothesis is that the luminal cell compartment is more complex than initially described, and that an understanding of the developmental relationships within this lineage will help in understanding the cellular context in which breast tumours occur. Methods: We used fluorescence-activated cell sorting along with in vitro and in vivo functional assays to examine the growth and differentiation properties of distinct subsets of human and mouse mammary epithelial cells. We also examined how loss of steroid hormones influenced these populations in vivo . Gene expression profiles were also obtained for all the purified cell populations and correlated to those obtained from breast tumours. Results: The luminal cell compartment of the mouse mammary gland can be resolved into nonclonogenic oestrogen receptor-positive (ER + ) luminal cells, ER + luminal progenitors and oestrogen receptor-negative (ER - ) luminal progenitors. The ER + luminal progenitors are unique in regard to cell survival, as they are relatively insensitive to loss of oestrogen and progesterone when compared with the other types of mammary epithelial cells. Analysis of normal human breast tissue reveals a similar hierarchical organisation composed of nonclonogenic luminal cells, and relatively differentiated (EpCAM + CD49f + ALDH - ) and undifferentiated (EpCAM + CD49f + ALDH + ) luminal progenitors. In addition, approximately one-quarter of human breast samples examined contained an additional population that had a distinct luminal progenitor phenotype, characterised by low expression of ERBB3 and low proliferative potential. Parent-progeny relationship experiments demonstrated that all luminal progenitor populations in both species are highly plastic and, at low frequencies, can generate progeny representing all mammary cell types. The ER - luminal progenitors in the mouse and the ALDH + luminal progenitors in the human appear to be analogous populations since they both have gene signatures that are associated with alveolar differentiation and resemble those obtained from basal-like breast tumours. Conclusion: The luminal cell compartment in the mammary epithelium is more heterogeneous than initially perceived since progenitors of varying levels of luminal cell differentiation and proliferative capacities can be identified. An understanding of these cells will be essential for understanding the origins and the cellular context of human breast tumours.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, genes that were up-regulated in highly clonogenic normal LPs (39) were skewed toward genes predicted to mark less-differentiated cells (Fig. 4B).”
From Single-cell transcriptional diversity is a hallmark of developmental potential (2020) · cites this paper as [39]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261
Nishimura, R., Osako, T., Nishiyama, Y., Tashima, R., Nakano, M., Fujisue, M., Toyozumi, Y., & Arima, N. (2013) · Oncology · doi:10.1159/000353099 · Cited by 13,166
Sørlie, T., Perou, C. M., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., Hastie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191367098 · Cited by 10,938
Prospective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370
Untangling the ErbB signalling network
Yarden, Y., & Sliwkowski, M. X. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35052073 · Cited by 6,974 · cited 2×
“(D) Gene expression analysis of ALDH+, ALDH- and ERBB3subpopulations relative to the comparator populations (nonclonogenic luminal (NCL)) for oestrogen receptor (ER), KRT14, MFG-E8, epidermal growth factor receptor (EGFR), GATA3, ERBB2, MUC1, ALDH1A3, LFT, AR, DACH1, ELF5, FOXA1, KRT19, myosin light chain kinase (MYLK…”
BackgroundElkablawy, M. A., Albasri, A. M., Mohammed, R. A., Hussainy, A. S., Nouh, M. M., & Alhujaily, A. S. (2016) · Saudi Medical Journal · doi:10.15537/smj.2016.2.12285 · Cited by 4,382
Ginestier, C., Hur, M. H., Charafe-Jauffret, E., Monville, F., Dutcher, J., Brown, M., Jacquemier, J., Viens, P., Kleer, C. G., Liu, S., et al. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.08.014 · Cited by 4,012
Hu, Y., & Smyth, G. K. (2009) · Journal of Immunological Methods · doi:10.1016/j.jim.2009.06.008 · Cited by 2,083
Generation of a functional mammary gland from a single stem cell
Shackleton, M., Vaillant, F., Simpson, K. J., Stingl, J., Smyth, G. K., Asselin-Labat, M.-L., Wu, L., Lindeman, G. J., & Visvader, J. E. (2006) · Nature · doi:10.1038/nature04372 · Cited by 2,005 · cited 11×
“Previous studies have demonstrated that mammary stem cells have features characteristic of basal cells, whereas the bulk of the progenitor cells display predominantly luminal features and have luminal-restricted development potential [8,9], although a recent report has demonstrated that a separate stem/progenitor cell…”
BackgroundMethodResultInfluentialSelf-citationSotiriou, C., Neo, S.-Y., McShane, L. M., Korn, E. L., Long, P. M., Jazaeri, A., Martiat, P., Fox, S. B., Harris, A. L., & Liu, E. T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1732912100 · Cited by 1,993
Cited by
Items 101–200 of 306
Élias, S., Morgan, M. A., Bikoff, E. K., & Robertson, E. J. (2017) · Nature Communications · doi:10.1038/s41467-017-01971-w · Cited by 44
Dynamic architectural interplay between leucocytes and mammary epithelial cells
Hitchcock, J. R., Hughes, K., Harris, O. B., & Watson, C. J. (2019) · FEBS Journal · doi:10.1111/febs.15126 · Cited by 40
Self-citationSheridan, J. M., Ritchie, M. E., Best, S. A., Jiang, K., Beck, T. J., Vaillant, F., Liu, K., Dickins, R. A., Smyth, G. K., Lindeman, G. J., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1187-z · Cited by 45
“The prospective isolation of mammary stem cells (MaSCs) that are able to give rise to an entire mammary tree upon transplantation at the single cell level [1,2] and the phenotypic identification of several mammary epithelial progenitor cell (MaPC) populations [3-6] have enhanced our current understanding of the differ…”
BackgroundDong, Q., Gao, H., Shi, Y., Zhang, F., Gu, X., Wu, A., Wang, D., Chen, Y., Bandyopadhyay, A., Yeh, I.-T., et al. (2016) · Aging · doi:10.18632/aging.101082 · Cited by 29
“Although we and others have proposed possible existence of ductal and alveolar basal progenitors in the basal cell lineage [32, 33], currently there are no markers enabling the separation of these two types of basal cells.”
Models of Breast Morphogenesis Based on Localization of Stem Cells in the Developing Mammary Lobule
Honeth, G., Schiavinotto, T., Vaggi, F., Marlow, R., Kanno, T., Shinomiya, I., Lombardi, S., Buchupalli, B., Graham, R. A., Gazińska, P., et al. (2015) · Stem Cell Reports · doi:10.1016/j.stemcr.2015.02.013 · Cited by 37
Liu, F., Pawliwec, A., Feng, Z., Yasruel, Z., Lebrun, J. J., & Ali, S. (2015) · Stem Cell Research · doi:10.1016/j.scr.2015.08.001 · Cited by 45
“This is an open access article under expression pattern of cell surface markers EpCAM and CD49f, a differentiation model of MaSC was proposed: EpCAM/CD49f (bipotent progenitors)-EpCAM/CD49f (luminal progenitors)EpCAM/CD49f (mature luminal cells) (Fu et al., 2014; Shehata et al., 2012).”
BackgroundMethodInfluentialPal, B., Chen, Y., Bert, A. G., Hu, Y., Sheridan, J. M., Beck, T. J., Shi, W., Satterley, K., Jamieson, P. R., Goodall, G. J., et al. (2015) · Breast Cancer Research · doi:10.1186/s13058-015-0585-0 · Cited by 40
“The precise nature of the intermediate cell types remains unclear but two or three distinct luminal progenitor subsets have been prospectively isolated from mouse and human mammary tissue, respectively [4, 7–9].”
BackgroundImproved detection of tumor suppressor events in single-cell RNA-Seq data
Teschendorff, A. E., & Wang, N. (2020) · npj Genomic Medicine · doi:10.1038/s41525-020-00151-y · Cited by 36
Self-citationExpansion of stem cells counteracts age-related mammary regression in compound Timp1/Timp3 null mice
Jackson, H. W., Waterhouse, P. D., Sinha, A., Kislinger, T., Berman, H. K., & Khokha, R. (2015) · Nature Cell Biology · doi:10.1038/ncb3118 · Cited by 38
Geng, A., Wu, T. H., Cai, C., Song, W., Wang, J., Yu, Q. C., & Zeng, Y. A. (2020) · eLife · doi:10.7554/elife.56434 · Cited by 35
“ER or PR cells, consisting 30 ~ 50% of luminal cells, can be enriched by surface expression of Sca1 (Regan et al., 2012; Shehata et al., 2012; Sleeman et al., 2007).”
BackgroundInfluentialInactivation of LATS1/2 drives luminal-basal plasticity to initiate basal-like mammary carcinomas
Kern, J. G., Tilston-Lünel, A., Federico, A. N., Ning, B., Mueller, A., Peppler, G. B., Stampouloglou, E., Cheng, N., Johnson, R. L., Lenburg, M. E., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34864-8 · Cited by 36
Mechanisms that clear mutations drive field cancerization in mammary tissue
Ciwinska, M., Messal, H. A., Hristova, H. R., Lutz, C., Bornes, L., Chalkiadakis, T., Harkes, R., Langedijk, N. S. M., Hutten, S. J., de Menezes, R. X., et al. (2024) · Nature · doi:10.1038/s41586-024-07882-3 · Cited by 40
Mammary Epithelial Cell Hierarchy in the Dairy Cow Throughout Lactation
Perruchot, M., Turrubiarte, M. A., Dufreneix, F., Finot, L., Lollivier, V., Chanat, E., Mayeur-Nickel, F., & Dessauge, F. (2016) · Stem Cells and Development · doi:10.1089/scd.2016.0098 · Cited by 32
“Inthehuman mammary gland, the combination of the cell-surface markers EpCAM (epithelial cell adhesion molecule) and CD49 f has served to identify basal cell populations [16,17].”
Turrubiarte, M. A., Perruchot, M., Finot, L., Mayeur-Nickel, F., & Dessauge, F. (2015) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00261.2015 · Cited by 31
“Moreover, MECs with high ALDH activity have often high self-renewing capacities and mammosphere-forming abilities (25).”
BackgroundResultMTSS1 suppresses mammary tumor-initiating cells by enhancing RBCK1-mediated p65 ubiquitination
Cong, M., Wang, Y., Yang, Y., Lian, C., Zhuang, X., Li, X., Zhang, P., Liu, Y., Tang, J., Yang, Q., et al. (2020) · Nature Cancer · doi:10.1038/s43018-019-0021-y · Cited by 32
Pfefferle, A. D., Spike, B. T., Wahl, G., & Perou, C. M. (2015) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-3262-6 · Cited by 32
Wu, A., Dong, Q., Gao, H., Shi, Y., Chen, Y., Zhang, F., Bandyopadhyay, A. M., Wang, D., Gorena, K. M., Huang, C., et al. (2016) · Scientific Reports · doi:10.1038/srep32190 · Cited by 36
“…was only able to assay basal MaSCs because luminal MaSCs (or progenitors) cannot repopulate the mammary gland in the cleared fat pad as efficiently as that of basal MaSCs 28,44 , which leaves in vitro colony forming assay the only option for luminal progenitor identification and quantification 41 .”
Zhang, Y., Li, F., Song, Y., Sheng, X., Ren, F., Xiong, K., Chen, L., Zhang, H., Liu, D., Lengner, C. J., et al. (2016) · The FASEB Journal · doi:10.1096/fj.201600387r · Cited by 30
“The Sca1(2)CD49b population are progenitor cells intermediate between the basal stem cells and the more differentiated cells (23).”
BackgroundConserved and variable: Understanding mammary stem cells across species
Rauner, G., Ledet, M. M., & de Walle, G. R. V. (2017) · Cytometry Part A · doi:10.1002/cyto.a.23190 · Cited by 28
El‐Gowily, A. H., Loutfy, S. A., Ali, E. M. M., Mohamed, T. M., & Mansour, M. A. (2021) · Pharmaceuticals · doi:10.3390/ph14030254 · Cited by 29
“The autophagosome level of MCF-7 treated cells, and isolated tumor cells of the mammary gland [97] were analyzed by flow cytometry using a proprietary fluorescent autophagosome marker (lex = 333/lem = 518 nm) of autophagy assay kit (#MAK138S, Sigma Aldrich, St.”
MethodRetractedErbB3 drives mammary epithelial survival and differentiation during pregnancy and lactation
Williams, M. M., Vaught, D., Joly, M. M., Hicks, D. J., Sanchez, V. M., Owens, P., Rahman, B., Elion, D. L., Balko, J. M., & Cook, R. S. (2017) · Breast Cancer Research · doi:10.1186/s13058-017-0893-7 · Cited by 29
Arendt, L. M., Keller, P. J., Skibinski, A., Goncalves, K., Naber, S. P., Buchsbaum, R. J., Gilmore, H. L., Come, S. E., & Kuperwasser, C. (2014) · Breast Cancer Research · doi:10.1186/s13058-014-0453-3 · Cited by 30
Knapp, D. J. H. F., Kannan, N., Pellacani, D., & Eaves, C. J. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.09.096 · Cited by 27
“Transcriptional and epigenomic data provide further support for this concept (Fridriksdottir et al., 2015; Joshi et al., 2015; Kannan et al., 2013; Pellacani et al., 2016; Shehata et al., 2012; Villadsen et al., 2007).”
BackgroundDeciphering the Mammary Stem Cell Niche: A Role for Laminin-Binding Integrins
Romagnoli, M., Cagnet, S., Chiche, A., Bresson, L., Baulande, S., de la Grange, P., Arcangelis, A. D., Kreft, M., Georges‐Labouesse, E., Sonnenberg, A., et al. (2019) · Stem Cell Reports · doi:10.1016/j.stemcr.2019.02.008 · Cited by 29
“The ECM may, therefore, be an important component of the mammary stem cellmicroenvironment, the stem cell niche (Asselin-Labat et al., 2007; Shackleton et al., 2006; Shehata et al., 2012; Stingl et al., 2006).”
BackgroundPascual, R., Martín, J., Salvador, F., Reina, Ó., Chanes, V., Millanes‐Romero, A., Suñer, C., Fernández‐Miranda, G., Bartomeu, A., Huang, Y., et al. (2020) · Science Advances · doi:10.1126/sciadv.aax3868 · Cited by 28
Nuclear Localized LSR: A Novel Regulator of Breast Cancer Behavior and Tumorigenesis
Reaves, D. K., Hoadley, K. A., Fagan‐Solis, K. D., Jima, D. D., Bereman, M. S., Thorpe, L., Hicks, J., McDonald, D. A., Troester, M. A., Perou, C. M., et al. (2016) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0085-t · Cited by 29
“Current studies support that both ERþ and ER tumors arise from ERþ progenitor cells, and others and we have identified LSR in both ERþ and ER tumors and breast cancer cell lines (22, 24).”
BackgroundMethodInfluentialO’Leary, K. A., Shea, M. P., Salituro, S., Blohm, C. E., & Schuler, L. A. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.08.011 · Cited by 26
“and progenitor surface markers, but few mature luminal cells, as previously observed (Asselin-Labat et al., 2010; Joshi et al., 2010; Shehata et al., 2012), and PRL did not substantially alter this pattern.”
BackgroundInfluentialTao, L., van Bragt, M. P. A., & Li, Z. (2015) · Stem Cell Reports · doi:10.1016/j.stemcr.2015.05.014 · Cited by 27
“, 2010), theyappeared to represent a mixed population of heterogeneous progenitor cells for ductal luminal cells and ALs (Shehata et al., 2012).”
BackgroundInfluentialDall, G., Vieusseux, J. L., Korach, K. S., Arao, Y., Hewitt, S. C., Hamilton, K. J., Dzierzak, E. A., Boon, W. C., Simpson, E. R., Ramsay, R. G., et al. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2016.12.022 · Cited by 28
“Since MaSCs have been reported to be abundant in the young breast (Russo and Russo, 1978a; Russo et al., 1982), 418 Stem Cell Reports j Vol. 8 j 417–431 j February 14, 2017 we analyzed the CD49fhi population for changes in SCA-1 with increasing age, after separation based on CD24 and CD49f.”
Di-Cicco, A., Petit, V., Chiche, A., Bresson, L., Romagnoli, M., Orian‐Rousseau, V., Vivanco, M. D., Medina, D., Faraldo, M. M., Glukhova, M. A., et al. (2015) · eLife · doi:10.7554/elife.06104 · Cited by 33
“Such separation was not possible with CD49b, the most recently described marker for characterizing luminal cell subsets (Shehata et al., 2012; De Silva et al., 2015).”
BackgroundInfluentialRomagnoli, M., Bresson, L., Di-Cicco, A., Pérez-Lanzón, M., Legoix, P., Baulande, S., de la Grange, P., Arcangelis, A. D., Georges‐Labouesse, E., Sonnenberg, A., et al. (2020) · Development · doi:10.1242/dev.181552 · Cited by 31
Englund, J. I., Cojoc, H., Blaas, L., Ritchie, A., Pentinmikko, N., Döhla, J., Munne, P., Patarroyo, M. E., Klefström, J., Ivaska, J., et al. (2021) · Development · doi:10.1242/dev.199281 · Cited by 27
Lacher, M. D., Bauer, G., Fury, B., Graeve, S., Fledderman, E. L., Petrie, T., Coleal‐Bergum, D., Hackett, T., Perotti, N. H., Kong, Y., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00776 · Cited by 26
“[GEO DataSet GSE35399 (31)], Lowe et al.”
BackgroundMethodInfluentialProgesterone Exposure and Breast Cancer Risk: Understanding the Biological Roots
Joshi, P. A., Goodwin, P. J., & Khokha, R. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.0512 · Cited by 28
Liu, T., Zhao, X., Lin, Y., Luo, Q., Zhang, S., Xi, Y., Chen, Y., Lin, L., Fan, W., Yang, J., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-22-0668 · Cited by 27
Self-citationSmits, B. M. G., Haag, J. D., Rissman, A. I., Sharma, D., Tran, A., Schoenborn, A. A., Baird, R. C., Peiffer, D. S., Leinweber, D. Q., Muelbl, M. J., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003549 · Cited by 25
“In later studies, c-kit and ALDH have been identified as more specific markers for luminal progenitor cell populations, illustrating the heterogenity of the luminal MEC population [23,24].”
BackgroundNair, S. J., Zhang, X., Chiang, H.-C., Jahid, M. J., Wang, Y., Garza, P., April, C., Salathia, N. S., Banerjee, T., Alenazi, F., et al. (2016) · Nature Communications · doi:10.1038/ncomms10913 · Cited by 27
“In further support, flow cytometry using established cell-surface markers for mammary epithelial cells 30 showed that total live luminal (CD49f med EpCAM high ) and myoepithelial (CD49f high EpCAM med ) cell populations of CKO mammary glands were equally reduced compared with their WT littermates…”
BRCA1-Dependent Transcriptional Regulation: Implication in Tissue-Specific Tumor Suppression
Zhang, X., & Li, R. (2018) · Cancers · doi:10.3390/cancers10120513 · Cited by 26
Tumor mutational landscape is a record of the pre-malignant statePreprint
Kübler, K., Karlić, R., Haradhvala, N. J., Ha, K., Kim, J., Kuzman, M., Jiao, W., Gakkhar, S., Mouw, K. W., Braunstein, L. Z., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/517565 · Cited by 21
Yip, H. Y. K., Chee, A., Ang, C., Shin, S., Ooms, L. M., Mohammadi, Z., Phillips, W. A., Daly, R. J., Cole, T. J., Bronson, R. T., et al. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.09.027 · Cited by 24
Zhou, Y., Ye, Z., Wei, W., Zhang, M., Huang, F., Li, J., & Cai, C. (2023) · npj Regenerative Medicine · doi:10.1038/s41536-023-00296-1 · Cited by 25
“Sca1 labels ER + luminal cells and a rare pool of bipotent basal cells in the mammary gland 51,52 , compared with control group, Sca1 hi luminal cells in M2 co-cultured organoids decreased signi fi cantly (from 62.1 ± 1.5% to 45.8 ± 3.1%, P 0.01) (Supplementary Fig.”
InfluentialGranit, R. Z., Slyper, M., & Ben‐Porath, I. (2013) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1252 · Cited by 26
p53 controls the plasticity of mammary luminal progenitor cells downstream of Met signaling
Chiche, A., Di-Cicco, A., Sesma-Sanz, L., Bresson, L., de la Grange, P., Glukhova, M. A., Faraldo, M. M., & Deugnier, M. (2019) · Breast Cancer Research · doi:10.1186/s13058-019-1101-8 · Cited by 24
Anstine, L. J., & Keri, R. A. (2019) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2019.24 · Cited by 23
“basal epithelial populations revealed that cells exhibiting stem-like properties were located within the basal fraction and could be enriched by FACS sorting using CD49fCD29CD24EpCAMSca1 expression as markers([22-25]).”
Integrin-mediated adhesion and mechanosensing in the mammary gland
Paavolainen, O., & Peuhu, E. (2020) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2020.10.010 · Cited by 29
Anoikis resistance in mammary epithelial cells is mediated by semaphorin 7a
Rutherford, T. R., Elder, A. M., & Lyons, T. R. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04133-5 · Cited by 23
Finot, L., Chanat, E., & Dessauge, F. (2018) · Scientific Reports · doi:10.1038/s41598-018-34691-2 · Cited by 35
Amphiregulin mediates the hormonal regulation on Rspondin-1 expression in the mammary gland
Cai, C., Geng, A., Wang, M., Yang, L. C., Yu, Q. C., & Zeng, Y. A. (2019) · Developmental Biology · doi:10.1016/j.ydbio.2019.10.006 · Cited by 22
“Hormone receptor-positive cells are predominantly in luminal layer and can be enriched and isolated by their surface Sca1 expression (Shehata et al., 2012).”
BackgroundAn essential role of CBL and CBL-B ubiquitin ligases in mammary stem cell maintenance
Mohapatra, B. C., Zutshi, N., An, W., Goetz, B. T., Arya, P., Bielecki, T. A., Mushtaq, I., Storck, M. D., Meza, J. L., Band, V., et al. (2017) · Development · doi:10.1242/dev.138164 · Cited by 21
“We therefore analyzed dissociated MECs from 6- or 8-week-old control or DKO mice by FACS, with staining for CD29 (ITGB1), CD24 and EpCAM, which separate MECs into basal (CD29 CD24 or EpCAM CD29) and luminal (CD29 CD24 or EpCAM CD29) populations (Shehata et al., 2012; Smalley et al., 2012).”
MethodChamberlin, T., Clack, M., Silvers, C., Kuziel, G. M., Thompson, V., Johnson, H. E., & Arendt, L. M. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-0789 · Cited by 21
“The luminal cells were further gated into Sca-1þCD49b ERaþ cells, Sca-1þCD49bþ ERaþ progenitor cells, and Sca-1 CD49bþ ERa cell populations (27).”
BackgroundDefining breast epithelial cell types in the single-cell era
Gray, G. K., Carlson, E. G., Lev, T., Marshall, B., Reed, A. D., Covarrubias, A. P. S., Twigger, A., Puig-Barbe, A., Thennavan, A., Omotoso, A. J., et al. (2025) · Developmental Cell · doi:10.1016/j.devcel.2025.06.032 · Cited by 25
SAU, A. C., Cabrita, M. A., & Pratt, M. A. C. (2017) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-17-0225 · Cited by 21
“Although the mammary stem cell genomic signature is most aligned with the normal-like subtype, the luminal progenitor signature more closely resembles the basal-like subtype (5).”
BackgroundJoyce, R., Pascual, R., Heitink, L. S., Capaldo, B. D., Vaillant, F., Christie, M., Tsai, M., Surgenor, E. E., Anttila, C. J. A., Rajasekhar, P., et al. (2024) · Nature Cell Biology · doi:10.1038/s41556-023-01315-5 · Cited by 20
Rauner, G., & Barash, I. (2015) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-015-9348-x · Cited by 19
“Expression of ALDH1, LMO4, Krt5 and Mfg-e8, which are also highly expressed in luminal progenitors inmice [24], was not significantly different.”
BackgroundPirsko, V., Čakstiņa, I., Priedite, M., Dortane, R., Feldmane, L., Nakazawa, M., Daneberga, Z., Gardovskis, J., & Miklaševičs, E. (2018) · Medicina · doi:10.3390/medicina54020011 · Cited by 22
“More recently, mammary epithelial cell lineage tracing and profiling experiments have delineated mammary gland developmental hierarchy and assessed the expression of their specific signatures in tumors of different intrinsic subtypes [8,14,20,21].”
BackgroundIntegrin-Rac signalling for mammary epithelial stem cell self-renewal
Olabi, S., Uçar, A., Brennan, K. R., & Streuli, C. H. (2018) · Breast Cancer Research · doi:10.1186/s13058-018-1048-1 · Cited by 19
Kunasegaran, K., Ho, V., Chang, T. H. T., De Silva, D., Bakker, M. L., Christoffels, V. M., & Pietersen, A. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110191 · Cited by 18
“In the non-pregnant adult mammary gland, proliferation is detected mostly in ER- luminal cells, and this is mirrored by their colony forming potential when plated on feeder layers [13,32].”
BackgroundResultInfluentialAhmed, M. I., Élias, S., Mould, A. W., Bikoff, E. K., & Robertson, E. J. (2016) · Development · doi:10.1242/dev.136358 · Cited by 19
“Recent studies have identified several distinct stem and progenitor cell subpopulations (Shackleton et al., 2006; Shehata et al., 2012; Stingl et al., 2006; Villadsen et al., 2007).”
BackgroundInfluentialIntratumoral Heterogeneity in Ductal Carcinoma In Situ: Chaos and Consequence
Sinha, V. C., & Piwnica-Worms, H. M. (2018) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-018-9410-6 · Cited by 17
Regan, J. L., & Smalley, M. J. (2020) · npj Breast Cancer · doi:10.1038/s41523-020-00175-8 · Cited by 18
Castillo‐Lluva, S., Hontecillas‐Prieto, L., Blanco‐Gómez, A., Sáez‐Freire, M. D. M., Cenador, M. B. G., García-Criado, J., Pérez‐Andrés, M., Orfao, A., Cañamero, M., Mao, J., et al. (2015) · Oncogene · doi:10.1038/onc.2015.224 · Cited by 18
Rooney, N., Wang, P., Brennan, K. R., Gilmore, A. P., & Streuli, C. H. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25390 · Cited by 20
“WhenMECs isolated from pregnant mice are stimulated with prolactin on 3D LrBM, they retain in vivo characteristics and differentiate to produce milk (Aggeler et al., 1991; Streuli et al., 1991).”
BackgroundPlasticity and Potency of Mammary Stem Cell Subsets During Mammary Gland Development
Lee, E.-M., Piranlioglu, R., Wicha, M. S., & Körkaya, H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092357 · Cited by 19
BCL11B Drives Human Mammary Stem Cell Self-Renewal In Vitro by Inhibiting Basal Differentiation
Miller, D. H., Jin, D. X., Sokol, E. S., Cabrera, J. R., Superville, D. A., Gorelov, R. A., Kuperwasser, C., & Gupta, P. B. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.01.036 · Cited by 21
“(E) Summary of bivalent and J-bivalent TF loci calls from ChIP-seq and RT-PCR results. lineage markers (EPCAM, GATA3, SOX9, KRT18, ETV6) (Abd El-Rehim et al., 2004; Asselin-Labat et al., 2007; Guo et al., 2012; Kouros-Mehr et al., 2006; Shehata et al., 2012; Su et al., 1996; Taylor-Papadimitriou et al., 1989; Tognon e…”
Androgen Receptor Signalling Promotes a Luminal Phenotype in Mammary Epithelial Cells
Tarulli, G. A., Laven‐Law, G., Shehata, M., Walters, K. A., Denis, I., Rahman, M. M., Handelsman, D. J., Dean, N. R., Tilley, W. D., & Hickey, T. E. (2018) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-018-9406-2 · Cited by 17
Self-citationVirtanen, S., Schulte, R., Stingl, J., Caldas, C., & Shehata, M. (2021) · Breast Cancer Research · doi:10.1186/s13058-021-01444-5 · Cited by 25
“Previous reports show that ALDH enriches for detection of progenitor/stem activity [3, 10, 36].”
BackgroundSelf-citationWu, J., & Crowe, D. L. (2015) · Oncology Reports · doi:10.3892/or.2015.4003 · Cited by 17
“MSCs give rise during mammary gland development to estrogen receptor (ER)-negative basal cells and the ER- luminal progenitor (LP) population which maintains ER+ and ER- luminal cells (6-8).”
BackgroundMammary lineage tracing: the coming of age
Šale, S., & Pavelić, K. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1817-7 · Cited by 17
Zhang, D.-J., Qi, R., Lan, X., & Liu, B. (2025) · Genome Research · doi:10.1101/gr.280281.124 · Cited by 21
“The presence of mature luminal cells in these regions indicates epithelial development, differentiation, and remodeling, processes commonly associated with aggressive tumor progression (Shehata et al. 2012).”
Cellular Plasticity in Mammary Gland Development and Breast Cancer
Wicker, M. N., & Wagner, K. (2023) · Cancers · doi:10.3390/cancers15235605 · Cited by 16
“The identification of specific markers and their application using flow cytometry to enrich multipotent stem cells and luminal epithelial progenitors (e.g., CD24, CD29, CD49f, EpCAM/SCA1, and CD61) were significant contributions that led to a revision of the mammary epithelial hierarchy [17–20].”
BackgroundERrrr…Where are the Progenitors? Hormone Receptors and Mammary Cell Heterogeneity
Tornillo, G., & Smalley, M. J. (2015) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-015-9336-1 · Cited by 18
“Other than ER and PR, only a relative small number of transcription factors, including Foxa1 [26, 29, 30], Msx2 [30], Myb [26, 30], Tbx3 [26], have been reported as specifically expressed in the hormone-sensing cell compartment.”
BackgroundInfluentialTornillo, G., Elia, A. R., Castellano, I., Spadaro, M., Bernabei, P., Bisarò, B., Leal, M. D. P. C., Pincini, A., Provero, P., Sapino, A., et al. (2013) · Stem Cells · doi:10.1002/stem.1403 · Cited by 17
Hormone-Sensing Mammary Epithelial Progenitors: Emerging Identity and Hormonal Regulation
Tarulli, G. A., Laven‐Law, G., Shakya, R., Tilley, W. D., & Hickey, T. E. (2015) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-015-9344-1 · Cited by 19
“When primary human and mouse MECs are segregated into lineage subsets based on their cell surface expression profile (reviewed in [134], see HS-MECs Proliferate, and Harbour a Progenitor Cell Population section), ELF5 is highest in the luminal alveolar MEC population [35, 36, 44, 135].”
BackgroundResultInfluentialAnjanappa, M., Cardoso, A. A., Cheng, L., Mohamad, S., Gunawan, A. M., Rice, S. E., Dong, Y., Li, L., Sandusky, G. E., Srour, E. F., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-3308 · Cited by 16
“These cells in normal breast are considered to be undifferentiated luminal progenitors with overlapping luminal and basal cell gene expression pattern (20).”
BackgroundWeighing the Risk: effects of Obesity on the Mammary Gland and Breast Cancer Risk
Hillers‐Ziemer, L. E., & Arendt, L. M. (2020) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-020-09452-5 · Cited by 21
Mori, H., Chen, J. Q., Cardiff, R. D., Pénzváltó, Z., Hubbard, N. E., Schuetter, L., Hovey, R. C., Trott, J. F., & Borowsky, A. D. (2017) · Breast Cancer Research · doi:10.1186/s13058-017-0892-8 · Cited by 14
“FoxA1 is expressed in ductal progenitor cells [63, 64].”
Ludwik, K. A., Sandusky, Z. M., Stauffer, K. M., Li, Y., Boyd, K. L., O'Doherty, G. A., Stricker, T. P., & Lannigan, D. A. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107931 · Cited by 17
“Further fractionation of the luminal cells by stem cells antigen-1 (Sca1) and integrin alpha 2 (CD49b) resulted in four populations with the gates for each experiment established using a fluorescence-minus-one strategy (Figure S2C; Shehata et al., 2012).”
MethodSilva, D. D., Kunasegaran, K., Ghosh, S., & Pietersen, A. M. (2015) · BMC Developmental Biology · doi:10.1186/s12861-015-0058-9 · Cited by 15
Elevated EDAR signalling promotes mammary gland tumourigenesis with squamous metaplasia
Williams, R., Jobling, S., Sims, A. H., Mou, C., Wilkinson, L., Collu, G. M., Streuli, C. H., Gilmore, A. P., Headon, D. J., & Brennan, K. R. (2021) · Oncogene · doi:10.1038/s41388-021-01902-6 · Cited by 17
Boecker, W., van Horn, L., Stenman, G., Stürken, C., Schumacher, U., Loening, T., Liesenfeld, L. F., Korsching, E., Gläser, D., Tiemann, K., et al. (2018) · Laboratory Investigation · doi:10.1038/s41374-018-0054-3 · Cited by 17
Regulation of Mammary Luminal Cell Fate and Tumorigenesis by p38α
Barrantes, I. D. B., Attolini, C. S., Slobodnyuk, K., Igea, A., Gregorio, S., Gawrzak, S., Gomis, R. R., & Nebreda, Á. R. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.11.021 · Cited by 15
“Gating strategies were as described previously (Prater et al., 2013; Shehata et al., 2012).”
BackgroundInfluentialReimagining Cancer: Moving from the Cellular to the Tissue Level
Demicheli, R., & Hrushesky, W. J. M. (2022) · Cancer Research · doi:10.1158/0008-5472.can-22-1601 · Cited by 13
Single-Cell Transcription Mapping of Murine and Human Mammary Organoids Responses to Female Hormones
Ortiz, J. R., Lewis, S. M., Ciccone, M. F., Chatterjee, D., Henry, S., Siepel, A. C., & dos Santos, C. O. (2024) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-023-09553-x · Cited by 14
Comprehensive identification, isolation, and culture of human breast cell types
Thi, K., Toro, K. D., Licón-Muñoz, Y., Sayaman, R. W., & Hines, W. C. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107637 · Cited by 14
“24).”
Usp16 modulates Wnt signaling in primary tissues through Cdkn2a regulation
Adorno, M., di Robilant, B. N., Sikandar, S. S., Acosta, V. H., Antony, J., Heller, C. H., & Clarke, M. F. (2018) · Scientific Reports · doi:10.1038/s41598-018-34562-w · Cited by 12
Luo, L., Santos, A., Konganti, K., Hillhouse, A., Lambertz, I. U., Zheng, Y., Gunaratna, R. T., Threadgill, D. W., & Fuchs‐Young, R. (2022) · Stem Cells · doi:10.1093/stmcls/sxab018 · Cited by 13
Identifying the murine mammary cell target of metformin exposure
Shehata, M., Kim, H., Vellanki, R. N., Waterhouse, P. D., Mahendralingam, M. J., Casey, A. E., Koritzinsky, M., & Khokha, R. (2019) · Communications Biology · doi:10.1038/s42003-019-0439-x · Cited by 11
Self-citationMiller, J. L., Kanke, M., Rauner, G., Bakhle, K. M., Sethupathy, P., & de Walle, G. R. V. (2022) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-022-09525-7 · Cited by 12
Baicalin Promotes Mammary Gland Development via Steroid-Like Activities
Chen, W., Wei, W., Yu, L., Zhang, X., Huang, F., Zheng, Q., Wang, L., & Cai, C. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.682469 · Cited by 11
Lysine metabolism is a novel metabolic tumor suppressor pathway in breast cancer
Wu, J., Kramer, K., & Crowe, D. L. (2023) · Oncogene · doi:10.1038/s41388-023-02766-8 · Cited by 10
Ding, L., Shunkwiler, L. B., Harper, N. W., Zhao, Y., Hinohara, K., Huh, S. J., Ekram, M. B., Guz, J., Kern, M. J., Awgulewitsch, A., et al. (2019) · PLoS Genetics · doi:10.1371/journal.pgen.1008002 · Cited by 13
Unraveling Heterogeneity in Epithelial Cell Fates of the Mammary Gland and Breast Cancer
Samocha, A. J., Doh, H. M., Kessenbrock, K., & Roose, J. P. (2019) · Cancers · doi:10.3390/cancers11101423 · Cited by 13
Valdés‐Mora, F., Salomon, R., Gloss, B., Law, A. M. K., Castillo, L. E., Murphy, K. J., Venhuizen, J., Magenau, A., Papanicolau, M., de la Fuente, L. R., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/624890 · Cited by 10
Differential DNA damage repair and PARP inhibitor vulnerability of the mammary epithelial lineages
Kim, H., Aliar, K., Tharmapalan, P., McCloskey, C. W., Kuttanamkuzhi, A., Grünwald, B. T., Palomero, L., Mahendralingam, M. J., Waas, M., Mer, A. S., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113256 · Cited by 11
Walton, B. N., Kaplan, N., Hrdlicka, B., Mehta, K. P. M., & Arendt, L. M. (2024) · Toxics · doi:10.3390/toxics12070484 · Cited by 10
“This indicates obesity may predispose individuals to breast cancer by expanding the epithelial populations that give rise to the most common subtypes of breast cancer [18–21].”
BackgroundMilevskiy, M. J. G., Coughlan, H. D., Kane, S. R., Johanson, T. M., Kordafshari, S., Chan, W. F., Tsai, M., Surgenor, E. E., Wilcox, S., Allan, R. S., et al. (2023) · Cell Genomics · doi:10.1016/j.xgen.2023.100424 · Cited by 13
“15,16 Thus, luminal lineage priming predominantly occurs in basal cells at the promoter level, while lineage priming of ML genes in the LP population occurs extensively at both promoter and enhancer regions.”
BackgroundR-loop functions in Brca1 -associated mammary tumorigenesis
Chiang, H.-C., Qi, L., Mitra, P., Huang, Y., Hu, Y., & Li, R. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2403600121 · Cited by 11
“Using CD49b as the established luminal progenitor marker (40) ( SI Appendix , Fig.”
Side branching and luminal lineage commitment by ID2 in developing mammary glands
Seong, J., Kim, N., Kim, J.-A., Lee, W., Seo, J., Yum, M. K., Kim, J.-H., Park, I., Kang, J., Bae, S.-H., et al. (2018) · Development · doi:10.1242/dev.165258 · Cited by 11
“…blockage of K6+ BPs developing into CD61+ LPs in Id2–/– mice, we performed flow cytometry analysis using CD49b (integrin-α2), a promising LP marker (Shehata et al., 2012), along with CD61, and revealed that most CD61+ cells were CD49b+ (98.44±0.44%), whereas ∼30.40±2.29% CD49b+ cells were CD61–.”
MethodInfluentialFresques, T., & LaBarge, M. A. (2020) · Aging and Cancer · doi:10.1002/aac2.12011 · Cited by 10
Acosta, D., Bagchi, S., Broin, P. Ó., Hollern, D. P., Racedo, S. E., Morrow, B. E., Sellers, R. S., Greally, J. M., Golden, A., Andrechek, E. R., et al. (2016) · Scientific Reports · doi:10.1038/srep35810 · Cited by 8
Metadata
- Authors
- Shehata, M., Teschendorff, A., Sharp, G., Novcic, N., Russell, I. A., Avril, S., Prater, M., Eirew, P., Caldas, C., Watson, C. J., & Stingl, J.
- Affiliations
- Cancer Research UK (GB)
- University College London (GB)
- University of Cambridge (GB)
- Corresponding author
- Shehata, Mona
- Venue
- Breast Cancer Research
- Published
- 2012-10-22
- Volume
- 14
- Issue
- 5
- Pages
- R134-R134
- ISSN
- 1465-5411 (ISSN-L)
- 1465-542X
- PMC
- PMC4053112
- OpenAlex
- W1999591980
- Cited by
- 306
- References
- 67
- Citations by year
- 2026: 9 · 2025: 9 · 2024: 18 · 2023: 16 · 2022: 14 · 2021: 25 · 2020: 28 · 2019: 29 · 2018: 27 · 2017: 24 · 2016: 15 · 2015: 43 · 2014: 33 · 2013: 14 · 2012: 2
- FWCI
- 14.56
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/2.0/ (tdm)
- creativecommons.org/licenses/by/2.0/ (vor)
- Locations
- Breast Cancer Research (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- eSpace (Curtin University) (submittedVersion, cc-by)
- Funders
- Cancer Research UK (10208)
- National Institute for Health and Care Research
- Breast Cancer Campaign
- University of Cambridge
- Hutchison Whampoa Limited
- NIHR Cambridge Biomedical Research Centre
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Keywords
- luminal progenitors, mammary gland development, oestrogen receptor, progesterone, ALDH+ cells, EpCAM, CD49f, HER3, alveolar differentiation, stem cell plasticity, gene expression profiling, human breast tissue
- MeSH terms
- Animals, Antigens, Surface, Cell Differentiation, Colony-Forming Units Assay, Epithelial Cells, Epithelium, Female, Humans, Mammary Glands, Animal, Phenotype, Receptors, Estrogen, Stem Cells, Immunophenotyping, Mammary Glands, Human, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.